Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06747572

Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

A Study to Determine the Prevalence and Clinical Characteristics Associated With PKD1 Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
401 (actual)
Sponsor
Vertex Pharmaceuticals Incorporated · Industry
Sex
All
Age
12 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to estimate the prevalence, demographic, and clinical characteristics of PKD1/2 gene variant groups in the ADPKD population.

Conditions

Timeline

Start date
2024-12-19
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2024-12-24
Last updated
2026-02-11

Locations

45 sites across 9 countries: United States, Belgium, Canada, France, Germany, Netherlands, Puerto Rico, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT06747572. Inclusion in this directory is not an endorsement.

Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease (NCT06747572) · Clinical Trials Directory